Guru Ownership Trend
Guru Analysis for enGene Therapeutics Inc. (ENGN)
enGene Therapeutics Inc. (ENGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $561,782.16.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.72 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 651.1%. Conversely, Steven Cohen reduced exposure by 69.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for enGene Therapeutics Inc. (ENGN)
Major holders include Steven Cohen ($1.18 M), Renaissance Technologies (RenTech) ($1.06 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 329,491 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.72 M, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ENGN. The total reported sell value was $2.65 M.
Yes, 0 managers opened new positions in ENGN, and 1 increased their existing holdings. The total reported buy value was $921,515.58.